Literature DB >> 19594624

Two different mechanisms of ampicillin resistance operating in strains of Vibrio cholerae O1 independent of resistance genes.

Dong Tu Nguyen1, Tuan Cuong Ngo, Huy Hoang Tran, Thi Phuong Lan Nguyen, Binh Minh Nguyen, Kouichi Morita, Masahiko Ehara.   

Abstract

Autoagglutinable strains of Vibrio cholerae O1 (seven nonfimbriate strains and one fimbriate strain) were transformed to obtain resistance to ampicillin. Two distinct mechanisms were found in these strains. One was operating in nonfimbriate strains by reducing OmpU protein production and the other was operating in a fimbriate strain (Bgd17) by newly overproducing cpxP protein. The twitching motility in the fimbriate Bgd17 strain disappeared depending on the production of cpxP protein, suggesting that fimbriation of V. cholerae O1 is controlled by a two-component signal transduction system.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19594624     DOI: 10.1111/j.1574-6968.2009.01693.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  3 in total

1.  Antibiotic resistance and plasmid profiling of Vibrio spp. in tropical waters of Peninsular Malaysia.

Authors:  K G You; C W Bong; C W Lee
Journal:  Environ Monit Assess       Date:  2016-02-16       Impact factor: 2.513

2.  Prediction of Antibiotic Susceptibility Profiles of Vibrio cholerae Isolates From Whole Genome Illumina and Nanopore Sequencing Data: CholerAegon.

Authors:  Valeria Fuesslin; Sebastian Krautwurst; Akash Srivastava; Doris Winter; Britta Liedigk; Thorsten Thye; Silvia Herrera-León; Shirlee Wohl; Jürgen May; Julius N Fobil; Daniel Eibach; Manja Marz; Kathrin Schuldt
Journal:  Front Microbiol       Date:  2022-06-22       Impact factor: 6.064

3.  Characterizing the host and symbiont proteomes in the association between the Bobtail squid, Euprymna scolopes, and the bacterium, Vibrio fischeri.

Authors:  Tyler R Schleicher; Spencer V Nyholm
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.